Form 8-K - Current report:
SEC Accession No. 0001641172-25-006499
Filing Date
2025-04-28
Accepted
2025-04-28 17:26:16
Documents
13
Period of Report
2025-04-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT form8-k.htm   iXBRL 8-K 22784
  Complete submission text file 0001641172-25-006499.txt   197051

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE thar-20250428.xsd EX-101.SCH 3020
3 XBRL LABEL FILE thar-20250428_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE thar-20250428_pre.xml EX-101.PRE 22362
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3787
Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Tharimmune, Inc. (Filer) CIK: 0001861657 (see all company filings)

EIN.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41210 | Film No.: 25881668
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)